missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Ephrin A2 Monoclonal Antibody (OTI4C3)

Descripción
Ephrin A2 Monoclonal Antibody for Western Blot, ICC/IF, Flow
The Eph subfamily represents the largest group of receptor protein tyrosine kinases identified to date. While the biological activities of these receptors have yet to be determined, there is increasing evidence that they are involved in central nervous system function and in development. The Eph subfamily receptors of human origin (and their murine/avian homologs) include EphA1(Eph), EphA2 (Eck), EphA3 (Hek4), EphA4 (Hek8), EphA5 (Hek7), EphA6 (Hek12), EphA7 (Hek11/MDK1), EphA8 (Hek3), EphB1 (Hek6), EphB2 (Hek5), EphB3(Cek10, Hek2), EphB4 (Htk), EphB5 (Hek9) and EphB6 (Mep). Ligands for Eph receptors include ephrin-A4 (LERK-4) which binds EphA3 and EphB1. In addition, Ephrin-A2 (Elf-1) has been described as the ligand for EphA4, ephrin-A3 (Ehk1-L) as the ligand for EphA5 and ephrin-B2 (Htk-L) as the ligand for EphB4 (Htk).
Especificaciones
Especificaciones
| Antígeno | Ephrin A2 |
| Aplicaciones | Flow Cytometry, Western Blot, Immunocytochemistry |
| Clasificación | Monoclonal |
| Clon | OTI4C3 |
| Concentración | 0.76 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 |
| génica | EFNA2 |
| N.º de referencia del gen | O43921 |
| Alias de gen | CEK7L; CEK7-L; CEK7-ligand; EFNA2; Elf1; ELF-1; EPH related receptor tyrosine kinase ligand 6; eph-related receptor tyrosine kinase ligand 6; ephrin A2; ephrin A-2; ephrin A6; EphrinA2; ephrin-A2; Epl6; EPLG6; HEK7 ligand; HEK7-L; Lerk6; LERK-6 |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?